All Updates

All Updates

icon
Filter
Product updates
DeepMind launches updated version of AlphaFold model for drug discovery
AI Drug Discovery
Oct 31, 2023
This week:
Management news
6K Additive awarded project to develop C-103 powder for additive manufacturing
Additive Manufacturing
Sep 27, 2024
Partnerships
WAAM3D partners with Innovative Space Carrier, Cranfield University, and Aichi Sangyo for space transport development
Additive Manufacturing
Sep 19, 2024
Product updates
Microsoft launches Face Check with Microsoft Entra Verified ID
Facial Recognition
Sep 11, 2024
Funding
3DEO raises USD 3.5 million in strategic investment from Mizuho Bank
Additive Manufacturing
Sep 6, 2024
Product updates
HyperWrite launches open-source AI model Reflection 70 billion
Generative AI Applications
Sep 5, 2024
Product updates
Google begins US rollout of AI-powered Ask Photos feature
Generative AI Applications
Sep 5, 2024
Funding
Management news
HDAX Therapeutics raises USD 3.2 million in seed funding to progress pipeline and advance preclinical candidates into trials
Precision Medicine
Sep 5, 2024
Partnerships
Sequentify partners with Dexter to expand genomic diagnostics in Romania
Precision Medicine
Sep 5, 2024
Partnerships
Elevate partners with Cultivatd for European expansion
Vertical Farming
Sep 5, 2024
Product updates
Moolec confirms harvest of its genetically engineered plant-grown products
Crop Biotech
Sep 5, 2024
AI Drug Discovery

AI Drug Discovery

Oct 31, 2023

DeepMind launches updated version of AlphaFold model for drug discovery

Product updates

  • Alphabet-owned AI company DeepMind has released an updated version of its AI system, AlphaFold, which can accurately predict the structures of proteins and other biological molecules. The system is leveraged by DeepMind's spin-off company, Isomorphic Labs for drug discovery.

  • The updated AlphaFold can predict the structures of proteins without any reference protein, whereas the previous versions required a docking protein to carry out these functions. In addition, this version can predict ligands, nucleic acids, and post-translational modifications. This can aid in drug discovery by identifying and designing new molecules with therapeutic potential.

  • DeepMind claims that its new AlphaFold model outperforms previous versions and shows the potential for AI to enhance scientific understanding of the human body's molecular machines. However, the system still falls short in predicting the structures of RNA molecules.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.